Hatch B12 Injection contains Methylcobalamin 1500 mcg, an active form of vitamin B12 essential for hematopoiesis and neurological function. This injectable formulation is indicated for the treatment and prevention of vitamin B12 deficiency, which may arise due to pernicious anemia, malabsorption syndromes, dietary insufficiency, or increased physiological demand. Methylcobalamin plays a crucial role in DNA synthesis, red blood cell formation, and maintenance of myelin sheath integrity, thereby supporting nerve health and cognitive function. Hatch B12 Injection is administered intramuscularly or subcutaneously, allowing rapid absorption and bioavailability compared to oral supplementation, particularly beneficial in patients with impaired gastrointestinal absorption. Clinical use of this preparation is recommended under medical supervision, with dosage tailored according to the severity of deficiency and patient response. Common adverse effects are rare but may include mild injection site reactions. Caution is advised in patients with hypersensitivity to cobalamin compounds. Hatch B12 Injection is contraindicated in individuals with known allergy to vitamin B12 or its components. Regular monitoring of hematological parameters and serum B12 levels is advisable during prolonged therapy to ensure efficacy and safety. This product provides an effective therapeutic option for correcting vitamin B12 deficiency and associated clinical manifestations.